相关实验视频

Updated: Sep 16, 2025

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

FVIII 通过使用CRISPR/Cas9特定基因淘汰来跨越亚细胞器官的贩运动态

Salime El Hazzouri¹, Rawya Al-Rifai¹, Nicole Surges¹

¹Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.

International journal of molecular sciences

|July 12, 2025

概括

第八因子 (FVIII) 的分泌受ER的陪伴者Calnexin (CANX) 和Calreticulin (CALR) 以及氨酸受体相关蛋白质 (GABARAPs) 的影响. 淘汰模式揭示了明显的FVIII贩运模式,影响治疗策略.

科学领域:

分子生物学分子生物学
细胞生物学细胞生物学
生物化学生化学

背景情况:

第八因子 (FVIII) 分泌对于血液静止至关重要,并受到内分泌网膜 (ER) 护卫者,如Calnexin (CANX) 和Calreticulin (CALR) 的影响.
胺黄油酸受体相关蛋白 (GABARAPs) 之前已经参与调节FVIII分泌.
了解FVIII细胞内贩运是开发有效的FVIII替代,细胞和基因疗法的关键.

研究的目的:

使用CRISPR/Cas9淘汰模型研究FVIII分泌的细胞内动力学.
阐明ER伴侣蛋白 (CANX,CALR) 和GABARAP蛋白在FVIII贩运中的作用.
评估细胞通路调节剂对FVIII分泌和局部化的影响.

主要方法:

产生单一和双 CRISPR / Cas9 淘汰 (KO) HEK293 细胞系,表达 CANX,CALR 和 GABARAP 蛋白质的 FVIII.
使用Brefeldin A (BFA),Chloroquine (CQ),一个Rab7抑制剂,以及葡萄糖饥饿来操纵细胞通路.
使用免疫光显微镜 (IF) 评估FVIII分泌通过两阶段染色分析和细胞内分布.

主要成果:

观察到单个蛋白质淘汰对FVIII贩运的明显影响.
在GABARAPKO,CANXKO和CALRKO细胞中聚集的FVIII表型,包括双KO组合.
在跨高尔基的内膜组件 (Rab8,Rab7,VAMP8) 的FVIII同位体化表明了额外的贩运因素的参与.

结论:

CANX,CALR和GABARAP在调节FVIII细胞内贩运方面发挥着重要的作用.
这项研究突出了伴侣蛋白和贩运蛋白在FVIII分泌中的复杂相互作用.
这些发现为FVIII分子机制提供了新的见解,可能为未来的治疗进展提供信息.

关键词:

这就是CRISPR/Cas9的作用.在ER/ERGIC的陪伴者.第八章人口贩运与自相关的蛋白质.细胞治疗细胞治疗光显微镜的光显微镜.

更多相关视频

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

Published on: August 28, 2018

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...